Cargando…

Effects of switching from anastrozole to letrozole, due to reimbursement policy, on the outcome of breast cancer therapy

BACKGROUND: Endocrine therapy is one of the standard treatments for estrogen-receptor-positive breast cancer patients. Letrozole is the only aromatase inhibitor (AI) included in Thailand’s essential drug list since the change of reimbursement policy in 2008, when patients had to change their AIs (ot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aphinives, Potchavit, Vachirodom, Damnern, Thanapaisal, Chaiyut, Rangsrikajee, Dhanes, Somintara, Ongart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154879/ https://www.ncbi.nlm.nih.gov/pubmed/25249759 http://dx.doi.org/10.2147/BCTT.S67553

Ejemplares similares

A comparison of letrozole and anastrozole followed by letrozole in breast cancer patients
por: Aphinives, Potchavit, et al.
Publicado: (2015)

Breast Cancer Incidence Trends and Projections in Northeastern Thailand
por: Virani, Shama, et al.
Publicado: (2018)

Joint symptoms associated with anastrozole and letrozole in patients with breast cancer: a retrospective comparative study
por: Morimoto, Yoshihito, et al.
Publicado: (2017)

Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole – of clinical importance?
por: Geisler, J
Publicado: (2011)

Women Commencing Anastrozole, Letrozole or Tamoxifen for Early Breast Cancer: The Impact of Comorbidity and Demographics on Initial Choice
por: Kemp, Anna, et al.
Publicado: (2014)

Comparative effectiveness of tamoxifen, toremifene, letrozole, anastrozole, and exemestane on lipid profiles in breast cancer patients: A network meta-analysis
por: He, Tao, et al.
Publicado: (2020)

Assessment of bone metabolism and biomechanical properties of the femur, following treatment with anastrozole and letrozole in an experimental model of menopause
por: Boutas, Ioannis, et al.
Publicado: (2017)

The diagnostic accuracy of mammography and ultrasonography for recurrent breast cancer after breast conserving treatment()
por: Pathanasethpong, Piyakan, et al.
Publicado: (2023)

A randomized double-blind controlled study comparing erector spinae plane block and thoracic paravertebral block for postoperative analgesia after breast surgery
por: Wittayapairoj, Aumjit, et al.
Publicado: (2022)

Adaptation to Open-Book Online Examination During the COVID-19 Pandemic
por: Eurboonyanun, Chalerm, et al.
Publicado: (2021)

Treatment Outcome of Traumatic Subclavian Artery Injuries
por: Tanmit, Parichat, et al.
Publicado: (2021)

Improvement of Bone Physiology and Life Quality Due to Association of Risedronate and Anastrozole
por: Monda, Vincenzo, et al.
Publicado: (2017)

A Life Saving Emergency Department Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) with Open Groin Technique
por: Teeratakulpisarn, Panu, et al.
Publicado: (2021)

Response of Mouse Breast Cancer Cells to Anastrozole, Tamoxifen, and the Combination
por: Xanthopoulos, J. M., et al.
Publicado: (2005)

Escitalopram co-prescription in anastrozole-treated breast cancer patients
por: Ozyurt, Hazan, et al.
Publicado: (2022)

Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment
por: Turković, Lu, et al.
Publicado: (2022)

A Life Saving Emergent Temporary External Carotid Artery Controlled in Extensive Craniofacial Injury
por: Tanmit, Parichat, et al.
Publicado: (2021)

Future Research and Policy Directions in Physician Reimbursement
por: McMenamin, Peter
Publicado: (1981)

Pharmaceutical pricing and reimbursement policies: perspectives for the future
por: Gray, Andrew L
Publicado: (2015)

Challenges and opportunities for pharmaceutical pricing and reimbursement policies
por: Vogler, Sabine, et al.
Publicado: (2015)

Clinical factors predictive of PCR positive in pandemic H1N1 2009 influenza virus infection
por: Phungoen, Pariwat, et al.
Publicado: (2011)

Effects of psoralen on the pharmacokinetics of anastrozole in rats
por: Zhang, Yuzhu, et al.
Publicado: (2018)

Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapy
por: GHIMENTI, CHIARA, et al.
Publicado: (2013)

Medicaid nursing home reimbursement policies, rates, and expenditures
por: Harrington, Charlene, et al.
Publicado: (1984)

Hospitalizations of nursing homes residents: the role of reimbursement policies
por: Ashton, Toni
Publicado: (2014)

Teledermatology: An updated overview of clinical applications and reimbursement policies()()
por: Campagna, M., et al.
Publicado: (2017)

Success of Big Infectious Disease Reimbursement Policy in China
por: Nie, Kun-xi, et al.
Publicado: (2020)

Evolving teledermatology policy and reimbursement landscape in the United States
por: Lin, Stephanie K., et al.
Publicado: (2023)

The effect of anastrozole on the pharmacokinetics of tamoxifen in post-menopausal women with early breast cancer
por: Dowsett, M, et al.
Publicado: (1999)

Differential effects of tamoxifen and anastrozole on optic cup size in breast cancer survivors
por: Eisner, Alvin, et al.
Publicado: (2007)

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action
por: Cairns, Junmei, et al.
Publicado: (2020)

Anastrozole (Arimidex ™) – an aromatase inhibitor for the adjuvant setting?
por: Buzdar, A U
Publicado: (2001)

Trend of minimally invasive and open surgery experience of general surgery residents: Accreditation Council for Graduate Medical Education general surgery case log in Thailand
por: Eurboonyanun, Chalerm, et al.
Publicado: (2023)

The Dilemma of Medical Reimbursement Policy in Rural China: Spatial Variability between Reimbursement Region and Medical Catchment Area
por: Dong, Yongqing, et al.
Publicado: (2019)

Efficacy, Safety, and Prognosis of Sequential Therapy with Tamoxifen and Letrozole versus Letrozole Monotherapy for Breast Carcinoma
por: Lu, Xinli, et al.
Publicado: (2022)

Drug-induced liver injury after switching from tamoxifen to anastrozole in a patient with a history of breast cancer being treated for hypertension and diabetes
por: Potmešil, Petr, et al.
Publicado: (2020)

Anastrozole-Induced Dermatitis: Report of a Woman with an Anastrozole-Associated Dermatosis and a Review of Aromatase Inhibitor-Related Cutaneous Adverse Events
por: Kim, Yoo Jung, et al.
Publicado: (2020)

A prospective, randomized study on hepatotoxicity of anastrozole compared with tamoxifen in women with breast cancer
por: Lin, Ying, et al.
Publicado: (2014)

Investigation of genotoxicity risk and DNA repair capacity in breast cancer patients using anastrozole
por: Tugce Yesil, Devecioglu, et al.
Publicado: (2018)

Cytotoxicity anticancer activities of anastrozole against breast, liver hepatocellular, and prostate cancer cells
por: Hassan, Firas, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9umagq7fvn90abah6m6s3e401a